Laura Antonucci

3PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 21, 2026
Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.

Laura Antonucci, Kosuke Watari, Yechen Feng

|Jan 25, 2024
The Past and Future of Inflammation as a Target to Cancer Prevention.

Laura Antonucci, Michael Karin

|Feb 19, 2021
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.

Yixuan Zhou, Ingmar Niels Bastian, Mark D Long

Pageof 1